Abstract
Introduction:
Acute leukemias are the most common malignancy of childhood, and acute lymphoblastic leukemia (ALL) is the most common subtype. In this study; we aimed to asses to acute endocrine and metabolic complications which occurs during treatment. Newly diagnosed ALL patients were included in the study.
Materials and Methods:
The endocrine and metabolic complication of 293 patients aged 1-18 years old who were newly diagnosed ALL between January 2007 and December 2017 in Uludağ University Faculty, Department of Pediatric Hematology were analyzed. Patients’ age, gender, risk groups, leukemia subtypes, and chemotherapy phases at the time of endocrine complications were noted.
Results:
In total, 250 patients were follow-up with B-ALL and 43 patients with T-ALL. 64% (n=188) of patients were male and 36% (n=105) were female. In our study, 36.4% of patients were in the high risk group but ten of the patients died before the risk group could be determined. During the two-year treatment, We found that 83% of the patients developed at least one endocrine complication. Hyperglycemia, osteoporosis and avascular necrosis were observed more frequently in patients older than 10 years at the time of diagnosis. The difference between the sexes was found only in vitamin D and was lower in girls. In regression analysis, only to be high risk group were found to be effective for the development of endocrine complications.
Conclusion:
Although the chemotherapeutics used today have prolonged the survival time, they have caused an increase in the incidence of complications. We think that these complications can be reduced by determining the risk factors in advance.
Keywords: Pediatric ALL, endocrine complication, chemotherapy
References
Yöntem A, Bayram İ. Acute Lymphoblastic Leukemia in Childhood. Archives Medical Review Journal 2018;27:485-99.
Tubergen DG, Bleyer A, Ritchey AK, Friehling E. The Leukemias. In: Kliegman RM, (eds). Nelson Textbook of Pediatrics. 20th edition. Philadelphia: Elsevier; 2016. p.2437-44.
Kutluk T, Yesilipek MA. Turkish National pediatric cancer registry 2002-2008 (Turkish Pediatric Oncology Group and Turkish Pediatric Hematology Society). Pediatric Blood Cancer 2009;53:851.
Serin T, Serin M, Erdem E, Yıldırmak Y. Çocukluk Çağı Lösemilerinde Risk Faktörleri. Türk Çocuk Hematoloji Dergisi 2007;9:26-31.
Crump C, Sundquist J, Sieh W, Winkleby MA, Sundquist K. Perinatal and familial risk factors for acute lymphoblastic leukemia in a Swedish national cohort. Cancer 2015;121:1040-7.
Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009;23:655-74.
Gutierrez A, Silverman LB. Acute Lymphoblastic Leukemia. In: Nathan (eds). Hematology and Oncology of Infancy and Childhood. 8th Edition. Elsevier Inc; 2015. p.1527-54.
Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;22:1030-43.
Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000;95:3310-22.
Shankar SM, Marina N, Hudson MM, Hodgson DC, Adams MJ, Landier W, et al. Monitoring for cardiovascular disease in survivors of childhood cancer: Report from the Cardiovascular Disease Task Force of the Children’s Oncology Group. Pediatrics 2008;121:e387-96.
Howard SC, Ribeiro RC, Pui CH. Acute complications. In: Pui CH (ed). Childhood leukemias. 3rd edition. New York: Cambridge University Pres; 2013. p.660-700.
Nathan PC, Wasilewski-Masker K, Janzen LA. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia. Hematol Oncol Clin North Am 2009;23:1065-82.
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Childhood Cancer Survivor Study.Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-82.
Brignardello E, Felicetti F, Castiglione A, Chiabotto P, Corrias A, Fagioli F, et al. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics. Eur J Endocrinol 2013;168:465-72.
U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. (cited 05.05.2021) Available from: URL: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf
Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, et al. Global consensus recommendations on prevention and management of nutritional Rickets. J Clin Endocrinol Metab 2016;101:394-415.
Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). Kılavuzlar. Available from: URL: https://temd.org.tr/yayinlar/kilavuzlar
Neyzi O, Günöz H, Furman A, Bunak R, Gökçay G, Darendeliler F, et al. Türk çocuklarında vücut ağırlığı, boy uzunluğu, baş çevresi ve vücut kitle indeksi referans değerleri. Çocuk Sağlığı ve Hastalıkları Dergisi 2008;51:1-14.
Möricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010;24:265-84.
Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: A report from the children’s oncology group. J Clin Oncol 2012:30;1663-9.
Güneş AM, Oren H, Baytan B, Bengoa SY, Evim MS, Gözmen S, et al. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol. Ann Hematol 2014;93:1677-84.
Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev 2002;16:225-43.
Öztürk P. Çocukluk Çağı Akut Lenfoblastik Lösemi Tedavisinde Karşılaşılan Tıbbi Sorunlar (Uzmanlık Tezi). İstanbul: İstanbul Üniversitesi; 2016.
Zawitkowska J, Lejman M, Zaucha-Prazmo A, Drabko K, Płonowski M, Bulsa J, et al. Grade 3 and 4 Toxicity Profiles During Therapy of Childhood Acute Lymphoblastic Leukemia. In Vivo 2019;33:133-9.
Karbuz A, Yaralı N, Işık P, Bay A, Kara A, Tunç B. Akut Lösemi Hastalarının Demografik Özellikleri ve Tedavi Sırasında Görülen Komplikasyonları: Tek Merkez Deneyimi. Türkiye Çocuk Hastalıkları Dergisi. 2017;1:19-26.
Öztürk AP, Koç B, Zülfikar B. Acute Complications and Survival Analysis of Childhood Acute Lymphoblastic Leukemia: A 15-year Experience. Clin Lymphoma Myeloma Leuk 2021;21:e39-47.
Lanzkowsky P. Leukemias. In: P. Lanzkowsky (ed). Manual of Peadiatric Hematol and Oncol 5th ed. New York: Churchill Livingstone; 2011;17:518-66.
Bayram C. Akut Lenfoblastik Lösemili Çocuklarda Tedavi Sonrası Ortaya Çıkan Kardiyak Ve Endokrin Geç Komplikasyonların Değerlendirilmesi. (Yandal Uzmanlık Tezi). Ankara: Ankara Çocuk Sağlığı ve Hastalıkları Hematoloji Onkoloji Eğitim ve Araştırma Hastanesi; 2014.
Bhattacharya S, Verma N, Kumar A. Prevalence of vitamin D deficiency in childhood acute lymphoblastic leukemia and its association with adverse outcomes during induction phase of treatment. Nutr Cancer 2020;72:1321-5.
Halonen P, Salo MK, Makipernaa A. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia. J Pediatr 2001;138:428-31.
Ziino O, Russo D, Orlando MA, Benigno V, Locatelli F, Arico M. Symptomatic hypoglycemia in children receiving oral pürine analogues for treatment of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 2002;39:32-4 .
Çalışkan S. Çocukluk Çağı Akut Lenfoblastik Lösemilerinde Tedavinin Kemik Mineral Metabolizmasına Etkileri. (Uzmanlık Tezi). İstanbul: İstanbul Üniversitesi; 2018.
Pui CH, Burghen GA, Bowman WP, Aur RJ. Risk factors for hyperglycemia in children with leukemia receiving sc l-asparaginase and prednisone. J Pediatr 1981;99:46-50.
Baillargeon J, Langevin AM, Mullins J, Ferry RJ Jr, DeAngulo G, Thomas PJ, et al. Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2005;45:960-3.
Mattano LA, Sather HN, Trigg ME. Nachman JB. osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Group. J Clin Oncol 2000;18:3262-72.
Aisyi M, Andriastuti M, Kurniati N. The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL). Asian Pac J Cancer Prev 2019;20:2619-24.
